Abstract
The diagnosis of myelodysplastic syndrome (MDS) based on morphology is particularly difficult in low-grade MDS. Thus, the role of myeloid nuclear differentiation antigen (MNDA) and other flow cytometric (FCM) parameters in MDS was evaluated. Bone marrow aspirates (BMA) collected from 52 patients with unexplained persistent cytopenias were divided into three groups: (i) proven MDS (n = 12) based on morphology and/or cytogenetics; (ii) suspected MDS (n = 6), noncontributory morphology, and cytogenetics; and (iii) non-MDS (n = 34). Sixteen control BMA were studied. Cases were analyzed for MNDA expression (on granulocytes, blasts, monocytes, and lymphocytes) and for seven quantitative parameters: CD34(+) myeloblasts % in nucleated cells, CD34(+) B-cell progenitor% in CD34(+) cells, lymphocyte/myeloblast CD45 MFI ratio, granulocyte/lymphocyte SSC peak channel ratio and the proportion of CD34(+) myeloblasts expressing CD15, CD11b, and CD56. A score of 1 was given to each parameter beyond the cutoff, and score ≥3 was considered FCM positive. MNDA expression on granulocytes and blasts was significantly lower in proven MDS and suspected MDS vs. non-MDS. Quantitative FCM parameters successfully distinguished MDS and suspected MDS from no...Continue Reading
References
Sep 24, 1999·Human Pathology·R N MirandaJ B Cousar
Aug 9, 2001·Blood·M Stetler-StevensonM E Rick
Jan 11, 2002·Blood·M Tarek Elghetany
Oct 24, 2002·Blood·Kiyoyuki OgataYataro Yoshida
Nov 2, 2002·Blood·Wolf-K HofmannH Phillip Koeffler
Mar 22, 2003·Blood·Denise A WellsH Joachim Deeg
Jan 23, 2004·Leukemia·A PradhanF V Rassool
Jan 26, 2005·Cytometry. Part B, Clinical Cytometry·Sindhu CherianAdam Bagg
Mar 25, 2005·Leukemia·L MalcovatiM Cazzola
May 3, 2006·Cancer Research·Robert C BriggsDavid R Head
May 13, 2006·American Journal of Clinical Pathology·Samuel J PirruccelloPatricia Aoun
Aug 7, 2007·Leukemia Research·Dariusz StachurskiSa A Wang
Nov 1, 2007·Blood·Arjan A van de LoosdrechtGert J Ossenkoppele
Apr 17, 2008·Hematological Oncology·Kiyoyuki Ogata
Feb 24, 2009·Leukemia Research·Francoise TruongSa A Wang
Apr 10, 2009·Blood·James W VardimanClara D Bloomfield
Jun 24, 2009·Haematologica·Kiyoyuki OgataKazuo Dan
Mar 4, 2010·Cytometry. Part B, Clinical Cytometry·Sergio MatarrazAlberto Orfao
Jun 24, 2010·Cancer·Wolfgang KernTorsten Haferlach
Feb 26, 2011·American Journal of Clinical Pathology·Sara A McClintock-TreepDavid R Head
Jun 16, 2011·Cytometry. Part B, Clinical Cytometry·Matteo Giovanni Della PortaUNKNOWN Italian Society of Cytometry (GIC)
Feb 7, 2012·Leukemia·T M WestersA A van de Loosdrecht
Apr 18, 2012·Cytometry. Part B, Clinical Cytometry·Frauke BellosWolfgang Kern
Apr 25, 2012·Annals of Hematology·Anita ChopraRajive Kumar
Jun 19, 2012·Journal of Clinical and Experimental Hematopathology : JCEH·Satoko OkaToshiaki Hanafusa
Jul 3, 2013·Leukemia & Lymphoma·Kate L Burbury, David A Westerman
Jun 13, 2014·Leukemia·A PorwitM C Béné
Sep 27, 2014·Cytometry. Part B, Clinical Cytometry·Frauke Bellos, Wolfgang Kern